ArticleFrontiers in pharmacology2025
Simplified flow cytometry-based assay for rapid multi-cytokine profiling and machine-learning-assisted diagnosis of inflammatory diseases.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Multiple cytokines detection represents a more robust way to predict the disease progression than a single cytokine, and flow cytometry (FCM)-based assays are increasingly used worldwide for multiple cytokines profile. Methods: Inspired by One-step concept of ELISA technology, here we reported the development of one-step FCM-based 12-plex cytokine assay to reduce operation and reaction times, in which all the reagents (including capture-antibody-modified beads and phycoerythrin-labeled detection antibodies) had mixed in the same reaction system and achieved similar performance to the conventional approach. Moreover, we used the lyophilization technique to remove the need for cold storage of reagents to further simplify the assay procedure. Results: We leveraged our technology to test clinical serum samples from patients with COVID-19 or HBV infectious diseases, and established supervised or unsupervised machine learning models to predict the severity or viral load and get deeper insights into the diseases. Discussion: Together, our results demonstrate a general and framework for convenient analysis of cytokine panel and have the potential to influence medical research and application in this field.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.